Jagged1 Binding Proteins for Lung Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for therapeutic agents that effectively target aberrant Notch signaling pathways, particularly in lung diseases, where existing treatments are inadequate.
Innovation Solution
Administration of an antigen binding protein specifically binding to Jagged1, with at least 90% amino acid sequence identity, which can be administered intravenously, by nebulization, or subcutaneously, to modulate Notch signaling and treat lung diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing treatments are used for lung diseases, then general treatment is provided, but they are inadequate for targeting aberrant Notch signaling pathways
Solution Approach 1:
The patent introduces an antigen binding protein as an intermediary agent that specifically binds to Jagged1, blocking its interaction with Notch receptors. This intermediary prevents the aberrant Notch signaling pathway activation without directly interfering with the pathway components, providing targeted therapy for lung diseases while maintaining general treatability
2Adaptability or versatility
If a highly specific antigen binding protein is used to target Jagged1, then specificity to Notch signaling pathway is improved, but treatment complexity increases
Solution Approach 1:
The patent extracts and isolates the specific binding function required for Jagged1 targeting by using antigen binding proteins that selectively recognize Jagged1 epitopes. This extraction approach provides high specificity without requiring complex multi-component systems, as the binding specificity is achieved through the inherent properties of the antigen binding protein structure
3Ease of operation
If multiple administration routes are provided for the antigen binding protein, then ease of operation is improved, but device complexity increases
Solution Approach 1:
The antigen binding protein is designed with universal properties that enable it to be administered through multiple routes (intravenous, subcutaneous, intramuscular, inhalation). This multi-functionality is achieved by formulating the protein in a way that maintains its stability and efficacy across different administration methods, eliminating the need for route-specific modifications
Data Source
AI summary
Methods of treating conditions related to lung disease using an antigen binding protein specific for the Jagged1 polypeptide are provided.